A wave of vaping knock-offs (in particular, JUUL clones) have been developed over the past two years — after a deadline was established by the U.S. Food and Drug Administration (FDA) to limit such items.
Can you imagine? Thirsting-for-profit startups discounting federal mandates and releasing in-demand products?
The FDA’s Aug. 8, 2016, deadline was set for companies to complete their short-term launches of hardware for new vapor devices and products. The was supposed to the end of product rollouts.
Well … it wasn’t.
An ongoing investigation by the FDA seeks to identify if a number of products have been placed on store shelves improperly over the past 24-plus months. In particular, the agency is targeting high-nicotine products and fruity flavors with high-appeal to minors, Reuters reported.
The FDA initially set the deadline to corral the fledgling industry and keep it under control. However, JUUL and a few other “established” companies were allowed to proceed without federal control for another four years.
To stem the tide of new sort-of-like JUUL products appearing on shelves through the U.S. without federal approval, the FDA is poised to go on the offensive. The agency said in a statement it “plans to take additional action on this front very soon.” And if let loose, expect “swift action wherever appropriate.”
Companies that have attempted to duplicate popular flavors to cut into JUUL’s national market dominance should take notice. They not only are putting their own organizations in federal peril but if a high number are reprimanded for releasing lower-priced knock-off products after the FDA deadline, it could hinder the long-term growth of the vaping industry, according to Reuters.
Well … it’s true.
Keep up with the latest vaping news from around the globe — check out our News page!